Avaí Bio, Inc. AVAI
$0.12
$0.0113.93%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -13.84% | 266.79% | 22.94% | -39.64% | -3.35% |
| Depreciation & Amortization | -20.00% | -58.86% | -66.67% | -66.67% | -66.67% |
| Other Operating Expenses | -- | -193.12% | 88.03% | -- | -- |
| Total Operating Expenses | -13.90% | 80.79% | 22.42% | -27.29% | -7.79% |
| Operating Income | 13.90% | -80.79% | -22.42% | 27.29% | 7.79% |
| Income Before Tax | -13.21% | -154.99% | -22.42% | 27.29% | 7.79% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.21% | -154.99% | -22.42% | 27.29% | 7.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.21% | -154.99% | -22.42% | 27.29% | 7.79% |
| EBIT | 13.90% | -80.79% | -22.42% | 27.29% | 7.79% |
| EBITDA | 13.84% | -76.79% | -26.43% | 26.01% | 5.54% |
| EPS Basic | -2.86% | -152.94% | -21.21% | 34.00% | 23.91% |
| Normalized Basic EPS | 4.55% | -1,200.00% | -19.05% | 34.38% | 24.14% |
| EPS Diluted | -2.86% | -152.94% | -21.21% | 34.00% | 23.91% |
| Normalized Diluted EPS | 4.55% | -1,200.00% | -19.05% | 34.38% | 24.14% |
| Average Basic Shares Outstanding | 11.97% | 1.25% | 0.75% | 11.34% | 18.68% |
| Average Diluted Shares Outstanding | 11.97% | 1.25% | 0.75% | 11.34% | 18.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |